SIM
ARRY

Strategic Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Strategic Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18,464
Closed -$136K – 142
2015
Q1 		$136K Buy
+18,464
New +$131K 0.05% 101

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Strategic Investment Management's ARRY Position: Q2 2015 in Review

Strategic Investment Management sold out of Array Biopharma Inc (ARRY) in Q2 2015, closing a stake of 18,464 shares — an estimated $136K sold.

Strategic Investment Management first reported a position in ARRY in Q1 2015 and held it in 1 quarter. The position peaked at $136K in Q1 2015. 148 funds tracked by Wall St. Rank hold ARRY as of Q2 2015.

  • Strategic Investment Management reported no remaining Array Biopharma Inc position as of Q2 2015 after selling out during the quarter.
  • Strategic Investment Management sold 18,464 Array Biopharma Inc shares in Q2 2015, an estimated $136K.
  • Strategic Investment Management first reported a position in Array Biopharma Inc in Q1 2015 and held it in 1 quarter.
  • Strategic Investment Management's Array Biopharma Inc position peaked at $136K in Q1 2015.
  • 148 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2015.

Based on Strategic Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.